Lifesaving cancer drugs are running out as doctors prepare for painful decisions

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyle(REUTERS)Essential chemotherapy drugs, including ifosfamide, cisplatin, and carboplatin, are facing severe shortages across the U.S. The scarcity is due to shipping delays, manufacturing problems, and some companies discontinuing medications, according to the FDA. Doctors are being forced to make difficult decisions, such as rationing available doses and prioritizing younger patients with a higher chance of recovery. Some medical practices are adapting by spacing out treatment times or scheduling consecutive appointments to ensure no medication is wasted. The Department of Health and Human Services is actively working with manufacturers and stakeholders to address shortages and explore solutions such as temporary importation. In fullSupplies of essential chemotherapy drugs are running low and experts fear rationing could soon beginThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Raccontata daindependent.co.ukmedicalxpress.com